DNA X, Inc. — financial distress indicators
Financial-health summary
DNA X, Inc.'s reported numbers place it in the 'Weak' financial-health band (distress score 59/100). The main indicators are negative book equity, consecutive annual losses and deep share-price drawdown. In its favour: high insider/promoter ownership (35%) aligns management with survival.
Stress by dimension
Share price — last 12 months
Indicators behind the score
Each red flag shows the evidence from the company’s own filings and the financial or legal principle behind it. Points add to the 0–100 score.
Equity is zero or negative.
A financial institution with no equity cushion is technically insolvent; regulators intervene before this point.
Net loss in each of the last two years.
Sustained losses at a lender usually mean credit losses are outrunning provisions — a risk-management failure.
Price is -77% from its 52-week high.
For financial firms a share-price run often precedes a deposit or funding run (confidence channel).
Annualised volatility is 127%.
High equity volatility raises the market-implied default probability.
Revenue vs net income
Cash generation
Debt vs cash vs equity
✅ Mitigating factors
- High insider/promoter ownership (35%) aligns management with survival.
📰 Recent news scan
- DNA X, Inc. Reports Second Quarter 2026 Financial ResultsYahoo Finance · 2026-08-19
⚖️ U.S. legal pathway — broker-dealer liquidation
- Stockbrokers and commodity brokers cannot reorganise under Chapter 11 (§109(d)); they liquidate under Chapter 7 (subchapters III/IV) or in a SIPA proceeding.
- SIPC protects customer accounts up to $500,000 (including $250,000 cash) for missing customer property — not market losses.
- Net-capital rule (SEC Rule 15c3-1) breaches are the regulatory early warning.
Frequently asked questions
What do DNA X, Inc.'s financial-health indicators show?
As of 2026-10-08, DNA X, Inc.'s public financial data places it in the 'Weak' band with a distress score of 59/100, driven by negative book equity, consecutive annual losses and deep share-price drawdown. This is a statistical screen of reported numbers — it does not mean the company is insolvent, has defaulted or will enter insolvency proceedings.
What is DNA X, Inc.'s financial distress score?
59/100 ('Weak').
What works in DNA X, Inc.'s favour?
High insider/promoter ownership (35%) aligns management with survival.
How are shareholders treated if a company enters insolvency?
In a Chapter 11 reorganisation the absolute priority rule pays secured lenders, then unsecured creditors, before shareholders — so existing shares are usually cancelled or heavily diluted. In Chapter 7 the company is liquidated and shareholders rarely recover anything.
Other Bank & Finance companies with distress indicators
- CaliberCos Inc. (CWD)Very weak 79/100
- loanDepot, Inc. (LDI)Weak 69/100
- Pineapple Financial Inc. (PAPL)Weak 69/100
- TeraWulf Inc. (WULF)Weak 68/100
- SHF Holdings, Inc. (SHFS)Weak 67/100
- Streamex Corp. (STEX)Weak 67/100
Methodology
Score = capped sum of rule-based red flags across seven dimensions (liquidity, solvency, profitability, cash flow, sales trend, market signal, news). Ohlson O-score (1980) gives an accounting-based 1-year failure probability; Merton distance-to-default (Bharath & Shumway 2008) gives a market-implied probability. Financial institutions use a capital-based rule set. Recalculated every trading day from the latest filings, prices and news.